Effects of Mulligan Mobilization With Movement Versus Kinesiotaping and Placebo on Knee Function and Injury -Related Outcomes in Basketball Players (Sport _MWM_RTC)

March 29, 2026 updated by: Selda Sokoli Veizaj, University Aleksander Moisiu Durres

Effects of Mulligan Mobilization With Movement Versus Kinesiotaping and Placebo on Knee Function and Injury -Related Outcomes in Basketball Players: A Parallel -Group Randomized Controlled Trial

This is a randomized RTC study where the KOS-ADLS score of athletes' functionality and the OSTRC score of sports overuse injuries were used as outcomes, which were measured before the start of treatment, 1 hour and 2 weeks after treatment. In this study, 3 forms of intervention were used: Mulligan, Kinesiotaping and placebo in young basketball players with knee injuries.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Study type: Randomized Clinical Trial RTC ,with three intervention groups. Population: young basketball players. The intervention will last 2 weeks. Outcomes: KOS-ADLS; OSTRC. Statistical analysis: Mixed ANOVA

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Albania
    • Tirana
      • Tirana, Tirana, Albania, 1001
        • Sports Club Training facilities

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Male and female basketball players Minimum of 2 years of sports experience Presence of knee injury Active participation in organized sports

Exclusion Criteria:

Previous knee surgery Knee instability Neurological disorders Refusal or contraindication to Mulligan mobilization

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mulligan Mobilization with movement MWM
Participants received MWM in the squot position with tibial glide by a physiotherapist licensed to apply the Mulligan technique. 2 times a week for 2 weeks with a duration of 5min.
Other: Mulligan Mobilization with movement MWM
Participants received the MWM technique in a squat position with a tibial glide by a physiotherapist certified in the mulligan concept twice a week for 2 weeks, the treatment lasted 5 minutes.
Active Comparator: Kinesiotaping
Participants in the kinesiotaping group were applied the same kinesiotaping pattern regardless of injury type, with a frequency of 2 times a week for 2 weeks.
Other: Kinesiotaping
Participants received the same kinesiotaping pattern regardless of injury type twice a week for 2 weeks for 5 minutes.
Placebo Comparator: Placebo
Placebo participants underwent a sham intervention to mimic the treatment without therapeutic effect twice a week for 2 weeks for 5 minutes.
Other: Placebo
Participants received a sham intervention to mimic the treatment without therapeutic effect twice a week for 2 weeks, lasting 5 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
KOS-SAS (ADLS)
Time Frame: Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention
The Activities of Daily Living Scale (ADLS) subscale of the Knee Outcome Survey evaluates symptoms and functional limitations during daily activities. Scores range from 0 to 100, with higher scores indicating better function.
Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overuse Injury Questionnaire - Oslo Sports Trauma Research Center (OSTRC)
Time Frame: Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention
The Oslo Sports Trauma Research Center (OSTRC) Overuse Injury Questionnaire is a validated self-report instrument used to monitor the severity and impact of overuse-related musculoskeletal problems. It evaluates the consequences of knee-related problems on sports participation, training volume, sports performance, and symptom severity. Responses to the four key questions are converted into a severity score ranging from 0 to 100, where higher scores indicate greater symptom severity and functional impairment.
Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sports Activity Scale (SAS) - Knee Outcome Survey.
Time Frame: Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention
The Sports Activity Scale (SAS) of the Knee Outcome Survey assesses knee symptoms and functional limitations during sports and higher-level activities. The scale ranges from 0 to 100, with higher scores indicating better sports-related knee function.
Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Aleksander Moisiu Durres

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • https://www.consort-statement.org
  • https://doi.org/10.1093/ptj/78.2.115
  • https://doi.org/10.1136/bjsports-2012-091524

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 6, 2025

Primary Completion (Actual)

June 27, 2025

Study Completion (Actual)

February 27, 2026

Study Registration Dates

First Submitted

March 11, 2026

First Submitted That Met QC Criteria

March 29, 2026

First Posted (Actual)

April 3, 2026

Study Record Updates

Last Update Posted (Actual)

April 3, 2026

Last Update Submitted That Met QC Criteria

March 29, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Sport_MWM_RTC_"2026
  • Sport_MWM_RTC (Other Identifier: University Aleksander Moisiu)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The individual participant data (IPD) from this study will not be shared due to ethical and privacy considerations. The study involves minor athletes (under 18 years old), and participant consent does not include data sharing with external researchers. To ensure confidentiality and comply with ethical approvals, the data will remain restricted to the study investigators.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Injuries

Clinical Trials on Mulligan Mobilization with movement MWM

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe